Sponsor Dossier
Pfizer
Sponsor Dossier for Pfizer. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ABRILADA
- Brand: ABRYSVO
- Brand: ADRIAMYCIN
- Brand: Alcoholic
- Brand: ALDACTONE
- Brand: ANZATAX
- Brand: ARICEPT
- Brand: AROMASIN
- Device (sponsor): Hypodermic needle, single-use, sterile
- Device (sponsor): Skin-cleaning wipe, sterile
- Device (sponsor): Skin-cleaning wipe, sterile
- Device (sponsor): Electronic insulin pen
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Holder, <specify>
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Self-injection aid
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Self-injection aid
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
About
Pfizer is an Australian Private Company with ABN 50008422348, registered in NSW. The company is active and registered for GST from 1 July 2000.
Portfolio
Pfizer has 126 brands on the ARTG, of which 112 are indexable and 106 carry a Product Information document. 66 brands are PBS-listed, 43 have a PBAC outcome on record, and 34 have an AusPAR on record. Notable brands include ABRILADA, ABRYSVO, ADRIAMYCIN, Alcoholic, ALDACTONE, ANZATAX, ARICEPT, AROMASIN, ATGAM, BENEFIX, BESPONSA, BICILLIN.
Therapeutic focus
— Oncology: 25 brands — Infectious Disease: 23 brands — Reproductive Health: 19 brands — Immunology: 11 brands — Haematology: 9 brands — Cardiology: 6 brands — Endocrinology: 6 brands — Neurology: 6 brands — Pain Management: 5 brands — Gastroenterology: 4 brands — Dermatology: 4 brands — Psychiatry: 3 brands — Musculoskeletal: 2 brands — Other: 1 brand — Oncology, Reproductive Health: 1 brand — Rare Disease: 1 brand
PBS footprint
66 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-05-01, across 43 brands with a PBAC outcome on record. The latest AusPAR is 2026-03-24, across 34 brands with an AusPAR on record.